Cargando…
Stem cell manufacturing /
Stem Cell Manufacturing discusses the required technologies that enable the transfer of the current laboratory-based practice of stem cell tissue culture to the clinic environment as therapeutics, while concurrently achieving control, reproducibility, automation, validation, and safety of the proces...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam, Netherlands ; Oxford, United Kingdom ; Cambridge, MA, USA :
Elsevier,
[2016]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn954195239 | ||
| 003 | OCoLC | ||
| 005 | 20231120112124.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 160729t20162016ne ob 001 0 eng d | ||
| 040 | |a IDEBK |b eng |e rda |e pn |c IDEBK |d OPELS |d YDX |d OCLCF |d OCLCQ |d N$T |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d U3W |d OCLCO |d OCLCA |d D6H |d CHVBK |d LQU |d S2H |d OCLCO |d OCLCA |d ORE |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 958096614 |a 958350490 |a 1105196723 |a 1105572848 | ||
| 020 | |a 0444632662 |q (electronic bk.) | ||
| 020 | |a 9780444632661 |q (electronic bk.) | ||
| 020 | |z 9780444632654 | ||
| 020 | |z 0444632654 | ||
| 024 | 7 | |a 10.1016/C2011-0-05619-3 |2 doi | |
| 035 | |a (OCoLC)954195239 |z (OCoLC)958096614 |z (OCoLC)958350490 |z (OCoLC)1105196723 |z (OCoLC)1105572848 | ||
| 050 | 4 | |a QH588.S83 | |
| 060 | 4 | |a QU 325 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.02/774 |2 23 |
| 245 | 0 | 0 | |a Stem cell manufacturing / |c edited by Joaquim M.S. Cabral, Instituto Superior T�ecnico, Universidade de Lisboa, Lisboa, Portugal ; Cl�audia Lobato de Silva, Instituto Superior T�ecnico, Universidade de Lisboa, Lisboa, Portugal ; Lucas G. Chase, Cellular Dynamics International, Inc. Madison, WI, USA ; Maria Margarida Diogo, Instituto Superior T�ecnico, Universidade de Lisboa, Lisboa, Portugal |
| 264 | 1 | |a Amsterdam, Netherlands ; |a Oxford, United Kingdom ; |a Cambridge, MA, USA : |b Elsevier, |c [2016] | |
| 264 | 4 | |c �2016 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index | ||
| 520 | |a Stem Cell Manufacturing discusses the required technologies that enable the transfer of the current laboratory-based practice of stem cell tissue culture to the clinic environment as therapeutics, while concurrently achieving control, reproducibility, automation, validation, and safety of the process and the product. The advent of stem cell research unveiled the therapeutic potential of stem cells and their derivatives and increased the awareness of the public and scientific community for the topic. The successful manufacturing of stem cells and their derivatives is expected to have a positive impact in the society since it will contribute to widen the offer of therapeutic solutions to the patients. Fully defined cellular products can be used to restore the structure and function of damaged tissues and organs and to develop stem cell-based cellular therapies for the treatment of cancer and hematological disorders, autoimmune and other inflammatory diseases and genetic disorders. |c Publisher | ||
| 588 | 0 | |a Online resource; title from PDF title page (ProQuest Ebook Central, viewed July 16, 2021) | |
| 650 | 0 | |a Stem cells |x Cultures and culture media. | |
| 650 | 0 | |a Stem cells. | |
| 650 | 2 | |a Stem Cells |0 (DNLM)D013234 | |
| 650 | 6 | |a Cellules souches |0 (CaQQLa)201-0058821 |x Cultures et milieux de culture. |0 (CaQQLa)201-0375487 | |
| 650 | 6 | |a Cellules souches. |0 (CaQQLa)201-0058821 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Stem cells |2 fast |0 (OCoLC)fst01132975 | |
| 700 | 1 | |a Cabral, Joaquim S., |e editor. | |
| 700 | 1 | |a Silva, Cl�audia L. da |q (Cl�audia Lobato da), |e editor. | |
| 700 | 1 | |a Chase, Lucas G., |e editor. | |
| 700 | 1 | |a Diogo, Maria Margarida, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Stem cell manufacturing. |d Amsterdam, Netherlands : Elsevier, �2016 |z 9780444632654 |z 0444632654 |w (OCoLC)949750294 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780444632654 |z Texto completo |